scholarly journals Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study

Oncology ◽  
2009 ◽  
Vol 77 (6) ◽  
pp. 395-399 ◽  
Author(s):  
Amy D. Tiersten ◽  
James Moon ◽  
Harriet O. Smith ◽  
Sharon P. Wilczynski ◽  
William R. Robinson ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Chemotherapy Resistance ◽  
Progression Free Survival ◽  
Oncology Group ◽  
Free Survival ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

2004 ◽  
Vol 95 (3) ◽  
pp. 506-512 ◽  
Author(s):  
Mace L. Rothenberg ◽  
P.Y. Liu ◽  
Sharon Wilczynski ◽  
William A. Nahhas ◽  
Gaye L. Winakur ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group study

1991 ◽  
Vol 27 (2) ◽  
pp. 135-138 ◽  
Author(s):  
Geoffrey Weiss ◽  
Stephanie Green ◽  
David S. Alberts ◽  
James Tate Thigpen ◽  
Harry E. Hines ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Line Treatment ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document